Skip to main content
MASS logo

MASS · 908 Devices Inc.

Track MASS — free
$9.45 -0.29 (-2.98%)
Market Cap
$405.01M
Shares
41.58M
Volume · Nov 16 123.2K Avg daily vol (3M) 409.62K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$9.74 Open$9.77 Day$9.35–10.02 52W close$5.09–12.87 Avg vol 30d388K Short int2.5M · 6.1% of shares · 7.1d Short vol66% Last earningsNov 10, 2026 DataDec 2020–Nov 2026 Filing10-Q · Nov 10

Up next

Mar 2, 2027 Est · unconfirmed · in 15 wks

Latest documents

2026
Nov 10
Earnings call
Revenue rises 35% as full-year guidance increases

908 Devices reported Q3 revenue of $19 million, up 35%, and raised full-year 2026 guidance to $68.5 to $70 million. Device shipments exceeded 300, raising the installed base to approximately 4,400, while adjusted EBITDA loss was $1.7 million.

5 source passages
908 Devices We delivered revenue of $19 million, up 35% year-over-year, driven by continued strength in our core business and underscoring the durability and momentum of the platform we've been building. Reflecting that momentum, we're raising the low end of our full-year 2026 revenue guidance and now expect revenue of $68.5 to $70 million. We shipped more than 300 devices in the quarter, a new company record, bringing our installed base to approximately 4,400 devices in the field. Adjusted EBITDA loss for the third quarter of 2026 was $1.7 million, compared to a loss of $1.8 million in the prior year period. Open the document at this passage
Nov 10
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue growth narrows losses and boosts placements

The company generated nine-month continuing-operations revenue of $48.4 million versus $38.8 million, while net losses narrowed to $28.4 million from $37.7 million. Handheld product placements rose to 673 from 497, and cumulative placements reached 4,409.

Revenue $18.95M ▲ 35.3% Net loss $4.58M Diluted EPS -$0.11
Read from the MD&A section
5 source passages
We generated revenue from continuing operations of $48.4 million and $38.8 million for the nine months ended September 30, 2026 and 2025, respectively, and incurred net losses from continuing operations of $28.4 million and $37.7 million for those same periods. During the three and nine months ended September 30, 2026 and 2025, our product placements (units recognized as revenue) were as follows: Handheld | | 308 | | 176 | | 673 | | 497 Our cumulative product placements consist of the following number of devices: Handheld | | 4,409 | | 3,512 Open the document at this passage
Nov 10
Current report 8-K
Revenue grows 35%, raising full-year outlook

908 Devices Inc. reported third-quarter revenue of $19.0 million, up 35% year-over-year, and raised full-year revenue guidance to $68.5 million to $70.0 million. It ended September 30, 2026 with $99.1 million in cash and no debt.

Financial results
4 source passages
908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported financial results for the quarter ended September 30, 2026. Revenue of $19.0 million for the third quarter of 2026, increasing 35% year-over-year 908 Devices updates its full year revenue guidance range to $68.5 million to $70.0 million (from $68.0 million to $70.0 million previously), raising the low end of the range and representing 22% to 25% growth compared to 2025 revenue. Cash, cash equivalents and marketable securities were $99.1 million as of September 30, 2026, with no debt outstanding. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$65.78M
Trailing 12 months
Net income (TTM)
−$24.25M
Trailing 12 months
Revenue growth YoY
+35.3%
Year over year
Operating margin
-42.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$99.12M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+13.8%
Year over year · more shares
Price change (1Y)
+67.6%
Trailing year
Short interest
6.1%
Latest settlement · 7.1 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 11, 2026
Q2 FY26

TL;DR. 908 Devices posted 23% Q2 revenue growth to $16.1M, more than halved its adjusted EBITDA loss to negative $1.9M, and raised the low end of its 2026 revenue outlook to $68-70M, while reporting an $11.9M net loss from continuing operations and pulling AVCAD out of guidance.

Bullish
  • + Q2 revenue grew 23% year-over-year to $16.1 million.
  • + Adjusted EBITDA loss improved by more than 50% year-over-year to negative $1.9M.
  • + Company raised the low end of 2026 revenue guidance to $68-70M (21-25% growth).
  • + Adjusted gross margin expanded 85 basis points to 57% in Q2.
  • + NearLab acquisition is ramping, with more than 35 devices sold in roughly two months post-close.
Bearish
  • − Net loss from continuing operations was $11.9 million in Q2 2026.
  • − AVCAD program contribution was removed from 2026 core guidance, with any contribution now upside-only.
  • − Recurring revenue grew only 4% year-over-year to $4.9 million.
  • − Q2 cash usage of $10.2 million included $13.5M for the NearLab acquisition.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg +14%
above
Price vs 50-day avg −13%
below
RSI (14) 40
neutral
MACD trend Negative
52-week position 60%
mid-range
Momentum
relative strength
Strong
1-month return −14%
trailing
6-month return +23%
trailing
YTD return +86%
this year
Relative strength +22%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $11 › 200d $9 — 50d above 200d
Institutional flow Accumulating
93 of 111 funds reported for Sep 30 · net +2.8M sh shares · +16 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
6.13% of shares out · ▼ -6.0% MoM · 7.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
111 holders — mid 3-yr range
Squeeze score 64
elevated · 0–100
Fundamentals
Excellent
Revenue growth +18%
Y/Y
Gross margin 51%
contracting
EPS growth +125%
Y/Y
Free cash flow $-24.6M
Balance sheet $70.5M
net cash
Quant / Vol
risk profile
Very High
Volatility 64%
annualized · 1-yr
Max drawdown −24%
past year
ATR 8.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 4
Latest guidance · from the Earnings Call filed Nov 10, 2026
Revenue · full year 2026 Raised $68.5M – $70M
May 6, 2026 $67M – $70M changed to Nov 10, 2026 $68.5M – $70M
prior FY $56.2M midpoint +23.2% Y/Y
Handheld product and service revenue · full year 2026 Raised $65.5M – $67M
May 6, 2026 $62M – $64M changed to Nov 10, 2026 $65.5M – $67M
OEM and funded partnerships, including contract revenue · full year 2026 Maintained $3M
Aug 11, 2026 $3M changed to Nov 10, 2026 $3M
Previous outlook earlier release · from the 8-K filed Aug 11, 2026

Still-open targets the latest release did not restate under the same label.

Growth compared to 2025 revenue · full year 2026 21% – 25%
Guided vs delivered · last 4 settled
Full year reported 2024 revenue full year 2024
guided $63M – $65M
$47.75M Miss −25.4%
Revenue full year 2023
guided $49M – $51M
$50.23M In line
Revenue full year 2022
guided $46M – $49M
$46.85M In line
Revenue full year 2021
guided $41M – $43M
$42.21M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+14% Bullish
Price vs 50-day avg
−13% Bearish
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
60% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $11 › 200d $9 — 50d above 200d
Institutional flow Accumulating
93 of 111 funds reported for Sep 30 · net +2.8M sh shares · +16 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
6.13% of shares out · ▼ -6.0% MoM · 7.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
111 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $5 Now $10 · 60% Range high $13
vs 200-day avg +14% vs 50-day avg -13%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA (Non-GAAP) non-GAAP -$4.45M Six Months Ended June 30, 2026 —
Adjusted EBITDA loss non-GAAP 1.9M Q2 2026 —
Adjusted Gross Margin Percentage (Non-GAAP) non-GAAP 57% Six Months Ended June 30, 2026 —
Adjusted Gross Profit (Non-GAAP) non-GAAP $16.86M Six Months Ended June 30, 2026 —
Devices placed 198 Q2 2026 —
Installed base 4,101 Q2 2026 —
Product Placements - Handheld 198 Three Months Ended June 30, 2026 filing —
Recurring revenue 4.9M Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MASS
908 Devices Inc.
this stock
$405.01M +85.5% +17.7% — 6.1%
ABT
Abbott Laboratories
$187.95B -13.4% +5.7% 40.5 1.1%
MDT
Medtronic plc
$131.57B +7.1% +8.4% 25.3 1.8%
SYK
Stryker Corp
$117.88B -11.9% +11.2% 33.0 1.7%
BSX
Boston Scientific Corp
$64.27B -53.5% +12.5% 18.8 2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
122
% held
74.1%
Reported
93 of 111
Top holder
First Light Asset Managem…
Held Float
View
Held by Funds
Fund positions
122
View
Short & Settlement
Short Interest Falling
Shares short
2.5M
Days to cover
7.1d
Change
-161.4K sh
View
Short Volume
Short vol %
66%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
416
Value
$5.0K
As of
Oct 14, 2026
View
Off-Exchange
Off-exchange %
36.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$56.2M
Net income (FY)
$19.5M
EPS diluted
$0.54
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 10, 2026
This year
18

The company generated nine-month continuing-operations revenue of $48.4 million versus $38.8 million, while net losses narrowed to $28.4 million from $37.7 million. Handheld product placements rose to 673 from 497, and cumulative placements reached 4,409.

View
Proposed Sales
Value
$64.0K
Shares
5.0K
Filed
Oct 6, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 11, 2026
View
Investor Relations
Latest news
908 Devices Reports Third Quarter…
Published
Nov 10, 2026
View

Performance

5D 20D 120D MTD YTD
MASS -7.8% -13.5% +23.0% -13.4% +85.5%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -10.4% -12.3% +22.5% -13.2% +74.9%
Key facts CIK 1555279 CUSIP 65443P102 13F (30d) 92 filings 78 filers Visit website Investor relations